Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause
EndocrinologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Menopause (New York, N.Y.)
- Publicado em
- 27 nov 2023
- Citações
- 45
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause
Antonia Morga, Mayank Ajmera, Emily Gao, Oscar Patterson-Lomba, Angela Zhao, Shayna Mancuso, Emad Siddiqui, Risa Kagan
Descritores MeSH
- Menopause
- Hot Flashes
- Bayes Theorem
- Estrogens, Conjugated (USP)
- Female
- Desvenlafaxine Succinate
- Humans
- Thiadiazoles
- Heterocyclic Compounds, 2-Ring
- Gabapentin
Veja também
Estudos relacionados
- Pharmacological Treatments for Menopausal Vasomotor Symptoms: A Systematic Review and Bayesian Network Meta-Analysis of Efficacy and Safety
- Effectiveness and safety of fezolinetant in alleviating vasomotor symptoms linked to Menopause.: A systematic review and Meta-Analysis
- Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause
- Efficacy and Safety of Fezolinetant for the Treatment of Menopause-Associated Vasomotor Symptoms: A Meta-analysis